Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching

Charles C. Vining,Kristine Kuchta,Darryl Schuitevoerder,Pierce Paterakos,Yaniv Berger,Kevin K. Roggin,Mark S. Talamonti,Melissa E. Hogg
DOI: https://doi.org/10.1002/jso.25942
2020-05-23
Journal of Surgical Oncology
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Reports on the safety of minimally invasive pancreaticoduodenectomy compared to open pancreaticoduodenectomy (OPD) have demonstrated mixed results. One study comparing robotic pancreaticoduodenectomy (RPD) vs OPD demonstrated decreased complications associated with RPD.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>To evaluate the morbidity of RPD vs OPD using a national data set.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>This is a retrospective cohort study from 2014 to 2017. Factors associated with complications in patients undergoing pancreaticoduodenectomy were evaluated using multivariate logistic regression (MVA) and propensity score matching (PSM).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Of 13 110 PDs performed over the study period, 12 612 (96.2%) were OPD and 498 (3.8%) were RPD. Patients who underwent RPD vs OPD were less likely to have any complications (46.8% vs 53.3%; <i>P </i> = .004), surgical complications (42.6% vs 48.6%; <i>P </i> = .008), wound complications (6.2% vs 9.1%; <i>P </i> = .029), clinically relevant postoperative pancreatic fistulas (11.9% vs 15.6%; <i>P </i> = .026), sepsis (6.2% vs 9.3%; <i>P </i> = .019), and pneumonia (1.6% vs 3.8%; <i>P </i> = .012). On MVA, OPD was associated with increased complications compared with RPD. On PSM analysis, OPD remained a significant predictor for any (OR, 1.29; 95% CI, 1.03‐1.61; <i>P </i> = .029) and surgical (OR, 1.26; 95% CI, 1.00‐1.58; <i>P </i> = .048) complications. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>This is the largest multicenter study to evaluate the impact of RPD on morbidity and suggests RPD is associated with decreased morbidity.</p></section>
oncology,surgery
What problem does this paper attempt to address?